BIOLASE, Inc.
BIOL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $4 | $30 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $6 | $4 | $5 |
| Inventory | $11 | $16 | $13 | $11 |
| Other Curr. Assets | $1 | $3 | $2 | $4 |
| Total Curr. Assets | $25 | $29 | $49 | $35 |
| Property Plant & Equip (Net) | $7 | $6 | $3 | $3 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $10 | $9 | $6 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $35 | $38 | $55 | $41 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $3 | $3 |
| Short-Term Debt | $3 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $2 | $2 | $2 | $2 |
| Other Curr. Liab. | $8 | $8 | $7 | $6 |
| Total Curr. Liab. | $20 | $18 | $14 | $11 |
| LT Debt | $13 | $14 | $15 | $18 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $1 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $16 | $15 | $16 | $20 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $35 | $33 | $30 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$317 | -$296 | -$268 | -$251 |
| AOCI | -$1 | -$1 | -$1 | -$0 |
| Other Equity | $315 | $302 | $293 | $262 |
| Total Equity | -$0 | $5 | $25 | $10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $35 | $38 | $55 | $41 |
| Net Debt | $9 | $12 | -$15 | $1 |